See the DrugPatentWatch profile for Kerendia
The price of Kerendia 10 mg varies depending on location and insurance coverage. However, without specific details on where you are located or your insurance plan, it is not possible to provide an exact price.
How much does Kerendia cost without insurance?
The retail price of Kerendia can be significant without insurance. For instance, one source indicates a price of $620.49 for 30 tablets of Kerendia 10 mg [1]. This figure is a general estimate and actual costs may differ.
Are there patient assistance programs for Kerendia?
For individuals facing financial challenges, patient assistance programs may offer financial support. These programs, often run by pharmaceutical companies or independent organizations, can help reduce out-of-pocket expenses for eligible patients. Information on such programs can typically be found on the drug manufacturer's website or through healthcare providers.
What is Kerendia used for?
Kerendia (finerenone) is a medication prescribed to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, kidney failure, kidney death, non-fatal cardiovascular events, cardiovascular death, and heart failure hospitalization in adults with chronic kidney disease (CKD) associated with type 2 diabetes [2].
When does Kerendia patent expiry occur?
The patent landscape for pharmaceuticals is complex and can involve multiple patents covering different aspects of a drug. Information regarding specific patent expiry dates for Kerendia is typically tracked by specialized services that monitor drug patents. For detailed information on Kerendia's patent status and potential expiry dates, resources like DrugPatentWatch.com are valuable [3].
What are the side effects of Kerendia?
Common side effects of Kerendia can include hyperkalemia (high potassium levels), hypotension (low blood pressure), and fatigue [2]. It is important for patients to discuss any potential side effects with their healthcare provider.
How does Kerendia work?
Kerendia is a non-steroidal mineralocorticoid receptor (MR) antagonist. By blocking the MR, it helps to reduce inflammation and fibrosis in the kidneys and cardiovascular system, thereby slowing the progression of kidney disease and reducing cardiovascular risk in patients with type 2 diabetes [2].
Who manufactures Kerendia?
Kerendia is manufactured by Bayer [4].
*
**Sources
1. https://www.goodrx.com/kerendia
2. https://www.kerendia.com/
3. https://drugpatentwatch.com/
4. https://www.bayer.com/